To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The tool integrates with others ...

WASHINGTON, Oct 20 (Reuters) - The Federal Reserve will go into a policy meeting next week with its view of the economy obscured by a U.S. government shutdown that has suspended the release of key ...

Gitex Global 2025 showcased a pivotal shift in the Middle East and Africa (MEA) region's approach to artificial intelligence (AI): a move from experimentation to enterprise-grade deployment. The event ...

TORONTO — Canada's main stock index was up more than 300 points in a broad-based rally, while U.S. stock markets were mixed on Friday as investors carried on without U.S. jobs data. “I think the ...

NEW YORK (AP) — Two of the nation's biggest real estate services companies are combining in a deal that will bring Century 21, Compass and several other major brokerage brands under the same umbrella.

Compass’ plans to acquire Anywhere Real Estate are part of the brokerage’s path to dominate the industry, and the seismic deal would push the new combined firm ahead of the residential firm pack. New ...

MongoDB (NASDAQ:MDB) has shifted its focus to U.S. enterprise opportunities, which could provide substantial upside in the quarters and years ahead as artificial intelligence use cases advance, ...

I use MongoDB Compass (v 1.46.10) on windows 11. Latest DocumentDB image running in Docker Desktop using WSL2. I use 27017 default MongoDB port. I've masked hostname, mac address and password below.

The Schneider Electric Prefabricated Modular EcoStruxure™ Pod enables customers to accelerate move-in-ready workspace delivery and reduce upfront infrastructure fit-out costs and simplified ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Texas-based company is eyeing ...

Shares of Compass Therapeutics rose after the biopharmaceutical company reported better-than-expected survival data from its continuing study of a cancer drug. The stock was up 16%, to $3.15, and have ...